27 Recruiting Now

Psychedelic Clinical Trials

Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.

Showing 4977 of 77 trials
Recruiting·Phase 2·MDMA

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Stephen Robert Marder

Post Traumatic Stress Disorder
Recruiting·Phase 2·MDMA

MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder

Patricia Suppes

PTSD
Recruiting·Phase 2·psilocybin

State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma

Baylor College of Medicine

PTSD
Recruiting·N/A·psilocybin

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Yale University

OCDMajor Depressive Disorder (MDD)Alcohol Use Disorder (AUD)+8 more
Recruiting·Phase 2·MDMA

MDMA-Assisted CBCT for PTSD vs CBCT RCT

Remedy

Post Traumatic Stress Disorder
Recruiting·Phase 1·psilocybin

Open-Label Psilocybin Study in Transdiagnostic Population

Yale University

TransdiagnosticDepression - Major Depressive DisorderAnxiety+5 more
Recruiting·Phase 4·ketamine

The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD

Margaux M. Salas, PhD

Neuropathic PainPTSD
Recruiting·Phase 2·MDMA

MDMA for AUD/PTSD Comorbidity

Carolina L Haass-Koffler

Alcohol Use DisorderPost Traumatic Stress Disorder
Recruiting·N/A·ketamine

RIVER At Home Ketamine Protocols

RIVER Foundation

Chronic ConditionChronic PainChronic Disease+3 more
Recruiting·Phase 1·ketamine

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

Yale University

Depressive Disorder, MajorPost Traumatic Stress Disorder
Recruiting·Phase 2·ketamine

Enhancing Week-long Psychological Treatment for PTSD With Ketamine

Yale University

Posttraumatic Stress Disorder
Recruiting·Phase 2·ketamine

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

Yale University

Depressive DisorderMajor Depressive DisorderBipolar Disorder+2 more
Suspended·Early Phase 1·ketamine

Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)

University of Wisconsin, Madison

Posttraumatic Stress Disorder
Terminated·Phase 2·MDMA

Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD

Lykos Therapeutics

PTSD
Terminated·Phase 4·ketamine

RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain

Johns Hopkins University

Acute PainWound CarePosttraumatic Stress Disorder
Terminated·Phase 2·ketamine

Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy

Yale University

Posttraumatic Stress Disorder
Terminated·Phase 2·MDMA

Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD

Lykos Therapeutics

Posttraumatic Stress Disorder
Unknown·Phase 1·ayahuasca

Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults

Advanced Integrative Medical Science Institute

Major DepressionPost Traumatic Stress Disorder
Unknown·Phase 2·MDMA

Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.

HaEmek Medical Center, Israel

Post Traumatic Stress DisorderMoral InjuryMDMA ('Ecstasy')
Unknown·Phase 2·psilocybin

Evaluation of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans

Combat Stress

PTSD
Unknown·Phase 2·psilocybin

Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder

Halucenex Life Sciences Inc.

Treatment Resistant DisordersPost Traumatic Stress Disorder
Unknown·Phase 2·ketamine

Ketamine and Epigenetic Aging

TruDiagnostic

DepressionPost Traumatic Stress Disorder
Unknown·Phase 3·MDMA

Epigenetics and MDMA-Assisted Psychotherapy for PTSD

University of Southern California

PTSD
Unknown·N/A·ketamine

TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD

The Cooper Health System

PTSD
Withdrawn·Phase 1·MDMA

The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.

Yale University

Post Traumatic Stress Disorder
Withdrawn·Phase 1·ketamine

Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD

University of New Mexico

PTSD
Withdrawn·Phase 2·MDMA

Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans

Lykos Therapeutics

PTSD
Withdrawn·Phase 2·MDMA

Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

Lykos Therapeutics

Posttraumatic Stress Disorder
Withdrawn·Phase 2·ketamine

To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD

Adriana Feder

PTSD
PreviousPage 2 of 2

Browse by Condition

View all conditions →

How to Join a Clinical Trial

Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.

1. Review

Read the trial details, eligibility criteria, and what participation involves.

2. Contact

Reach out to the study team using the contact information provided.

3. Screen

Complete the screening process to determine if you're eligible.